US equities
|
SPCX
$166.82
▲+4.94%
NVDA
$236.79
▲+1.22%
MU
$1,063.93
▼-1.02%
TSLA
$376.93
▲+1.71%
MSFT
$524.46
▲+1.34%
SNDK
$1,706.48
▼-0.79%
INTC
$117.63
▼-1.42%
META
$742.44
▲+1.97%
SPCX
$166.82
▲+4.94%
NVDA
$236.79
▲+1.22%
MU
$1,063.93
▼-1.02%
TSLA
$376.93
▲+1.71%
MSFT
$524.46
▲+1.34%
SNDK
$1,706.48
▼-0.79%
INTC
$117.63
▼-1.42%
META
$742.44
▲+1.97%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cytodyn Inc
(OP:
CYDY
)
0.2030
+0.0030 (+1.50%)
Delayed Quote
Updated: 12:14 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytodyn Inc
< Previous
1
2
3
4
5
6
Next >
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages CytoDyn Inc. Investors with Losses to Secure Counsel Before Important May 17 Deadline in Securities Class Action – CYDY
May 02, 2021
From
The Rosen Law Firm, P.A.
Via
Business Wire
CytoDyn Inc. (OTC:CYDY) Investor Notice: Lawsuit Alleges Misleading Statements by CytoDyn Inc
↗
April 27, 2021
San Diego, CA -- (SBWIRE) -- 04/27/2021 -- An investor, who purchased shares of CytoDyn Inc. (OTC:CYDY), filed a lawsuit against CytoDyn Inc over alleged violations of Federal Securities Laws.
Via
SBWire
Topics
Lawsuit
CYDY Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds CytoDyn, Inc. Investors With Losses Exceeding $100K of Class Action and Encourages Shareholders to Contact the Firm
April 13, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Shareholder Alert: Robbins LLP Announces that CytoDyn Inc. (CYDY) is Being Sued for Misleading Shareholders
April 12, 2021
From
Robbins LLP
Via
Business Wire
Why Auris Medical, CytoDyn and Prometheus Shares Are Moving Today
↗
April 08, 2021
Auris Medical Holding Ltd. (NASDAQ: EARS), CytoDyn Inc. (OTC: CYDY) and Prometheus Biosciences, Inc. (NASDAQ: RXDX) are among the biggest movers in the biopharma space Thursday....
Via
Benzinga
Scott+Scott Attorneys at Law LLP Alerts Investors with Losses Over $250,000 to Securities Class Action Against CytoDyn, Inc. (CYDY)
April 07, 2021
From
Scott+Scott Attorneys at Law LLP
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >